2023-2029 Global Rectal Mesalazine Industry Research & Trends Analysis Report
This report aims to provide a comprehensive study of the global market for Rectal Mesalazine. Report Highlights:
(1) Global Rectal Mesalazine market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Rectal Mesalazine market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Rectal Mesalazine market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Rectal Mesalazine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Rectal Mesalazine segment by type and by application and regional segment by type and by application.
(6) Rectal Mesalazine industry supply chain, upstream, midstream and downstream analysis.
According to YH Research, the global market for Rectal Mesalazine should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Rectal Mesalazine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Rectal Mesalazine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Suppository segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Ulcerative Colitis has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Rectal Mesalazine include Ferring Global, AbbVie, Reid-Rowell, Dr. Falk Pharma UK and Alaven Pharmaceutical, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Suppository
Enema
Market segment by application, can be divided into
Ulcerative Colitis
Crohn's Disease
Inflammatory Bowel Disease
Market segment by players, this report covers
Ferring Global
AbbVie
Reid-Rowell
Dr. Falk Pharma UK
Alaven Pharmaceutical
1 Market Overview
1.1 Product Overview and Scope of Rectal Mesalazine
1.2 Global Rectal Mesalazine Market Size and Forecast
1.3 China Rectal Mesalazine Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Rectal Mesalazine Share in Global Market, 2018-2029
1.4.2 Rectal Mesalazine Market Size: China VS Global, 2018-2029
1.5 Rectal Mesalazine Market Dynamics
1.5.1 Rectal Mesalazine Market Drivers
1.5.2 Rectal Mesalazine Market Restraints
1.5.3 Rectal Mesalazine Industry Trends
1.5.4 Rectal Mesalazine Industry Policy
2 Global Competitive Situation by Company
2.1 Global Rectal Mesalazine Revenue by Company (2018-2023)
2.2 Global Rectal Mesalazine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Rectal Mesalazine Concentration Ratio
2.4 Global Rectal Mesalazine Mergers & Acquisitions, Expansion Plans
2.5 Global Rectal Mesalazine Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Rectal Mesalazine Revenue by Company (2018-2023)
3.2 China Rectal Mesalazine Rectal Mesalazine Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Rectal Mesalazine, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Rectal Mesalazine Industry Chain
4.2 Rectal Mesalazine Upstream Analysis
4.3 Rectal Mesalazine Midstream Analysis
4.4 Rectal Mesalazine Downstream Analysis
5 Sights by Type
5.1 Rectal Mesalazine Classification
5.1.1 Suppository
5.1.2 Enema
5.2 By Type, Global Rectal Mesalazine Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Rectal Mesalazine Revenue, 2018-2029
6 Sights by Application
6.1 Rectal Mesalazine Segment by Application
6.1.1 Ulcerative Colitis
6.1.2 Crohn's Disease
6.1.3 Inflammatory Bowel Disease
6.2 By Application, Global Rectal Mesalazine Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Rectal Mesalazine Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Rectal Mesalazine Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Rectal Mesalazine Market Size, 2018-2029
7.3 North America
7.3.1 North America Rectal Mesalazine Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Rectal Mesalazine Market Size Market Share
7.4 Europe
7.4.1 Europe Rectal Mesalazine Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Rectal Mesalazine Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Rectal Mesalazine Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Rectal Mesalazine Market Size Market Share
7.6 South America
7.6.1 South America Rectal Mesalazine Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Rectal Mesalazine Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Rectal Mesalazine Market Size & CAGR，2018 VS 2022 VS 2029
8.2 By Country, Global Rectal Mesalazine Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Rectal Mesalazine Market Size, 2018-2029
8.3.2 By Company, U.S. Rectal Mesalazine Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Rectal Mesalazine Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Rectal Mesalazine Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Rectal Mesalazine Market Size, 2018-2029
8.4.2 By Company, Europe Rectal Mesalazine Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Rectal Mesalazine Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Rectal Mesalazine Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Rectal Mesalazine Market Size, 2018-2029
8.5.2 By Company, China Rectal Mesalazine Revenue Market Share, 2018-2023
8.5.3 By Type, China Rectal Mesalazine Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Rectal Mesalazine Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Rectal Mesalazine Market Size, 2018-2029
8.6.2 By Company, Japan Rectal Mesalazine Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Rectal Mesalazine Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Rectal Mesalazine Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Rectal Mesalazine Market Size, 2018-2029
8.7.2 By Company, South Korea Rectal Mesalazine Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Rectal Mesalazine Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Rectal Mesalazine Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Rectal Mesalazine Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Rectal Mesalazine Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Rectal Mesalazine Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Rectal Mesalazine Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Rectal Mesalazine Market Size, 2018-2029
8.9.2 By Company, India Rectal Mesalazine Revenue Market Share, 2018-2023
8.9.3 By Type, India Rectal Mesalazine Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Rectal Mesalazine Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Rectal Mesalazine Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Rectal Mesalazine Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Rectal Mesalazine Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Rectal Mesalazine Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Ferring Global
9.1.1 Ferring Global Company Information, Head Office, Market Area and Industry Position
9.1.2 Ferring Global Company Profile and Main Business
9.1.3 Ferring Global Rectal Mesalazine Models, Specifications and Application
9.1.4 Ferring Global Rectal Mesalazine Revenue and Gross Margin, 2018-2023
9.1.5 Ferring Global Recent Developments
9.2 AbbVie
9.2.1 AbbVie Company Information, Head Office, Market Area and Industry Position
9.2.2 AbbVie Company Profile and Main Business
9.2.3 AbbVie Rectal Mesalazine Models, Specifications and Application
9.2.4 AbbVie Rectal Mesalazine Revenue and Gross Margin, 2018-2023
9.2.5 AbbVie Recent Developments
9.3 Reid-Rowell
9.3.1 Reid-Rowell Company Information, Head Office, Market Area and Industry Position
9.3.2 Reid-Rowell Company Profile and Main Business
9.3.3 Reid-Rowell Rectal Mesalazine Models, Specifications and Application
9.3.4 Reid-Rowell Rectal Mesalazine Revenue and Gross Margin, 2018-2023
9.3.5 Reid-Rowell Recent Developments
9.4 Dr. Falk Pharma UK
9.4.1 Dr. Falk Pharma UK Company Information, Head Office, Market Area and Industry Position
9.4.2 Dr. Falk Pharma UK Company Profile and Main Business
9.4.3 Dr. Falk Pharma UK Rectal Mesalazine Models, Specifications and Application
9.4.4 Dr. Falk Pharma UK Rectal Mesalazine Revenue and Gross Margin, 2018-2023
9.4.5 Dr. Falk Pharma UK Recent Developments
9.5 Alaven Pharmaceutical
9.5.1 Alaven Pharmaceutical Company Information, Head Office, Market Area and Industry Position
9.5.2 Alaven Pharmaceutical Company Profile and Main Business
9.5.3 Alaven Pharmaceutical Rectal Mesalazine Models, Specifications and Application
9.5.4 Alaven Pharmaceutical Rectal Mesalazine Revenue and Gross Margin, 2018-2023
9.5.5 Alaven Pharmaceutical Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Tables and Figures
Table 1. Rectal Mesalazine Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Rectal Mesalazine Market Restraints
Table 3. Rectal Mesalazine Market Trends
Table 4. Rectal Mesalazine Industry Policy
Table 5. Global Rectal Mesalazine Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Rectal Mesalazine Revenue Market Share by Company (2018-2023)
Table 7. Global Rectal Mesalazine Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Rectal Mesalazine Mergers & Acquisitions, Expansion Plans
Table 9. Global Rectal Mesalazine Manufacturers Product Type
Table 10. China Rectal Mesalazine Revenue by Company (2018-2023) & (US$ million)
Table 11. China Rectal Mesalazine Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Rectal Mesalazine Upstream (Raw Materials)
Table 13. Global Rectal Mesalazine Typical Customers
Table 14. Rectal Mesalazine Typical Distributors
Table 15. By Type, Global Rectal Mesalazine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Rectal Mesalazine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Rectal Mesalazine Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Rectal Mesalazine Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Rectal Mesalazine Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Rectal Mesalazine Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Rectal Mesalazine Revenue Market Share, 2018-2029
Table 22. Ferring Global Company Information, Head Office, Market Area and Industry Position
Table 23. Ferring Global Company Profile and Main Business
Table 24. Ferring Global Rectal Mesalazine Models, Specifications and Application
Table 25. Ferring Global Rectal Mesalazine Revenue and Gross Margin, 2018-2023
Table 26. Ferring Global Recent Developments
Table 27. AbbVie Company Information, Head Office, Market Area and Industry Position
Table 28. AbbVie Company Profile and Main Business
Table 29. AbbVie Rectal Mesalazine Models, Specifications and Application
Table 30. AbbVie Rectal Mesalazine Revenue and Gross Margin, 2018-2023
Table 31. AbbVie Recent Developments
Table 32. Reid-Rowell Company Information, Head Office, Market Area and Industry Position
Table 33. Reid-Rowell Company Profile and Main Business
Table 34. Reid-Rowell Rectal Mesalazine Models, Specifications and Application
Table 35. Reid-Rowell Rectal Mesalazine Revenue and Gross Margin, 2018-2023
Table 36. Reid-Rowell Recent Developments
Table 37. Dr. Falk Pharma UK Company Information, Head Office, Market Area and Industry Position
Table 38. Dr. Falk Pharma UK Company Profile and Main Business
Table 39. Dr. Falk Pharma UK Rectal Mesalazine Models, Specifications and Application
Table 40. Dr. Falk Pharma UK Rectal Mesalazine Revenue and Gross Margin, 2018-2023
Table 41. Dr. Falk Pharma UK Recent Developments
Table 42. Alaven Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 43. Alaven Pharmaceutical Company Profile and Main Business
Table 44. Alaven Pharmaceutical Rectal Mesalazine Models, Specifications and Application
Table 45. Alaven Pharmaceutical Rectal Mesalazine Revenue and Gross Margin, 2018-2023
Table 46. Alaven Pharmaceutical Recent Developments
List of Figure
Figure 1. Rectal Mesalazine Picture
Figure 2. Global Rectal Mesalazine Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Rectal Mesalazine Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Rectal Mesalazine Market Share of Global
Figure 5. Global Rectal Mesalazine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Rectal Mesalazine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Rectal Mesalazine Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Rectal Mesalazine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Rectal Mesalazine Industry Chain
Figure 10. Suppository
Figure 11. Enema
Figure 12. By Type, Global Rectal Mesalazine Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global Rectal Mesalazine Revenue Market Share, 2018-2029
Figure 14. Ulcerative Colitis
Figure 15. Crohn's Disease
Figure 16. Inflammatory Bowel Disease
Figure 17. By Application, Global Rectal Mesalazine Revenue, 2018-2029, US$ Million
Figure 18. By Application, Global Rectal Mesalazine Revenue Market Share, 2018-2029
Figure 19. By Region, Global Rectal Mesalazine Revenue Market Share, 2018-2029
Figure 20. North America Rectal Mesalazine Revenue & Forecasts, 2018-2029, US$ Million
Figure 21. By Country, North America Rectal Mesalazine Revenue Market Share, 2018-2023
Figure 22. Europe Rectal Mesalazine Revenue & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, Europe Rectal Mesalazine Revenue Market Share, 2018-2023
Figure 24. Asia Pacific Rectal Mesalazine Revenue & Forecasts, 2018-2029, US$ Million
Figure 25. By Country/Region, Asia Pacific Rectal Mesalazine Revenue Market Share, 2018-2023
Figure 26. South America Rectal Mesalazine Revenue & Forecasts, 2018-2029, US$ Million
Figure 27. By Country, South America Rectal Mesalazine Revenue Market Share, 2018-2023
Figure 28. Middle East & Africa Rectal Mesalazine Revenue & Forecasts, 2018-2029, US$ Million
Figure 29. U.S. Rectal Mesalazine Revenue, 2018-2029, (US$ Million)
Figure 30. By Company, U.S. Rectal Mesalazine Market Share, 2018-2023
Figure 31. By Type, U.S. Rectal Mesalazine Revenue Market Share, 2022 VS 2029
Figure 32. By Application, U.S. Rectal Mesalazine Revenue Market Share, 2022 VS 2029
Figure 33. Europe Rectal Mesalazine Revenue, 2018-2029, (US$ Million)
Figure 34. By Company, Europe Rectal Mesalazine Market Share, 2018-2023
Figure 35. By Type, Europe Rectal Mesalazine Revenue Market Share, 2022 VS 2029
Figure 36. By Application, Europe Rectal Mesalazine Revenue Market Share, 2022 VS 2029
Figure 37. China Rectal Mesalazine Revenue, 2018-2029, (US$ Million)
Figure 38. By Company, China Rectal Mesalazine Market Share, 2018-2023
Figure 39. By Type, China Rectal Mesalazine Revenue Market Share, 2022 VS 2029
Figure 40. By Application, China Rectal Mesalazine Revenue Market Share, 2022 VS 2029
Figure 41. Japan Rectal Mesalazine Revenue, 2018-2029, (US$ Million)
Figure 42. By Company, Japan Rectal Mesalazine Market Share, 2018-2023
Figure 43. By Type, Japan Rectal Mesalazine Revenue Market Share, 2022 VS 2029
Figure 44. By Application, Japan Rectal Mesalazine Revenue Market Share, 2022 VS 2029
Figure 45. South Korea Rectal Mesalazine Revenue, 2018-2029, (US$ Million)
Figure 46. By Company, South Korea Rectal Mesalazine Market Share, 2018-2023
Figure 47. By Type, South Korea Rectal Mesalazine Revenue Market Share, 2022 VS 2029
Figure 48. By Application, South Korea Rectal Mesalazine Revenue Market Share, 2022 VS 2029
Figure 49. Southeast Asia Rectal Mesalazine Revenue, 2018-2029, (US$ Million)
Figure 50. By Company, Southeast Asia Rectal Mesalazine Market Share, 2018-2023
Figure 51. By Type, Southeast Asia Rectal Mesalazine Revenue Market Share, 2022 VS 2029
Figure 52. By Application, Southeast Asia Rectal Mesalazine Revenue Market Share, 2022 VS 2029
Figure 53. India Rectal Mesalazine Revenue, 2018-2029, (US$ Million)
Figure 54. By Company, India Rectal Mesalazine Market Share, 2018-2023
Figure 55. By Type, India Rectal Mesalazine Revenue Market Share, 2022 VS 2029
Figure 56. By Application, India Rectal Mesalazine Revenue Market Share, 2022 VS 2029
Figure 57. Middle East & Asia Rectal Mesalazine Revenue, 2018-2029, (US$ Million)
Figure 58. By Company, Middle East & Asia Rectal Mesalazine Market Share, 2018-2023
Figure 59. By Type, Middle East & Asia Rectal Mesalazine Revenue Market Share, 2022 VS 2029
Figure 60. By Application, Middle East & Asia Rectal Mesalazine Revenue Market Share, 2022 VS 2029
Figure 61. Research Methodology
Figure 62. Breakdown of Primary Interviews
Figure 63. Bottom-up Approaches
Figure 64. Top-down Approaches
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets